The Academic Programs Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the academic legal community. The Committee discusses various programs, publications, pricing, dissemination vehicles, etc. that best facilitate expanding FDLI’s educational mission.

Judith K. Meritz, Esq., Baker, Donelson, Bearman, Caldwell & Berkowitz, PC
Chair

Ralph F. Hall, University of Minnesota
Vice Chair

Barry A. Berger, Temple University

James N. Czaban, Wiley Rein LLP

Lewis A. Grossman, JD, PhD, Covington & Burling LLP

William M. Janssen, Esquire, Charleston Law School

Philip Katz, Hogan & Hartson LLP

Eleanor D. Kinney, Indiana University School of Law - Indianapolis

William H. Kitchens, Arnall Golden Gregory LLP

Annemarie Martin-Boyan, Temple University

Francis B. Palumbo, PhD, JD, University of Maryland School of Pharmacy

Peter O. Safir, Covington & Burling LLP

Sheila R. Shulman, State University of NY at Buffalo

Victoria Sutton, PhD, JD, Texas Tech University

Roseann B. Termini, JD, MEd, Widener University School of Law

Geoffrey M. Levitt, Pfizer, Inc.
Chair

James N. Czaban, Wiley Rein LLP

Coleen E. Klasmeier, Sidley Austin LLP

Stuart J. Land, Arnold & Porter LLP

The H. Thomas Austern Writing Awards Committee assists FDLI staff in determining the award recipient(s) for the best student papers submitted for publication. Members of the Committee (with subcommittees for long and short papers) develop publicity for and promote the competition, and subsequently review all submitted student manuscripts, determining which are most appropriate for awards and/or publication.

James N. Czaban, Wiley Rein LLP
Chair

Bruce Patsner, MD, JD, University of Houston
Vice Chair

Thomas E. Colonna, PhD, JD,

Lewis A. Grossman, JD, PhD, Covington & Burling LLP

David M. Gryte, AstraZeneca Pharmaceuticals

Christina M. Markus, King & Spalding LLP

Christine Mulshine, Children's Medical Center-Ambulatory Care Pavilion

The H. Thomas Austern Writing Awards Committee assists FDLI staff in determining the award recipient(s) for the best student papers submitted for publication. Members of the Committee (with subcommittees for long and short papers) develop publicity for and promote the competition, and subsequently review all submitted student manuscripts, determining which are most appropriate for awards and/or publication.

Philip Katz, Hogan & Hartson LLP
Chair

Michael D. Bernstein, Esq., FDA - CDER

Paul L. Ferrari, Esq.,

Michael M. Gaba, Holland & Knight, LLP

Matthew R. Kyle, Millennium Medical Technologies, Inc.

Peter R. Mathers, Kleinfeld, Kaplan & Becker

Roseann B. Termini, JD, MEd, Widener University School of Law

Matthew B. Van Hook, U.S. Pharmacopeia

Kirke Weaver, Merck & Co., Inc.

Frederick H. Degnan, King & Spalding LLP
Chair

William B. Schultz, Zuckerman Spaeder LLP
Immediate Past Chair

Susan C. Winckler, RPh, JD, FDLI
President & CEO

Jeffrey N. Gibbs, Hyman, Phelps & McNamara, P.C.
Secretary and General Counsel

Linda A. Suydam, DPA, Consumer Healthcare Products Association
Treasurer

Minnie V. Baylor-Henry, JD, Deloitte & Touche LLP
Vice Chair

Robert E. Brackett, Ph.D., Grocery Manufacturers Association

Mark S. Frankel, Ph.D., American Association for the Advancement of Science

Christopher L. Hagenbush, Patton Boggs LLP

Ralph F. Hall, University of Minnesota

Sheila M. Hemeon-Heyer, JD, RAC, Boston Scientific Corporation Inc.

Philip Katz, Hogan & Hartson LLP

Geoffrey M. Levitt, Pfizer, Inc.

Erika Lietzan, Covington & Burling LLP

Patricia B. Shrader, BD

The Drugs and Biologics Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the drugs and biologics industries. The Committee advises staff on the appropriateness of conferences and publications relating to pharmaceuticals and biologics by reviewing and commenting on proposals.

Bruce Artim, Eli Lilly and Company

Deborah M. Autor, JD, FDA - CDER

Edward Berg, Sanofi-Aventis

Shawn M. Brown, Generic Pharmaceutical Association

Andrew C. Fish, Consumer Healthcare Products Association

Philip Katz, Hogan & Hartson LLP

Patricia Knight, FoxKiser

Daniel A. Kracov, Arnold & Porter LLP

Daniel Meron, Latham & Watkins

Joseph W. Metro, Reed Smith LLP

Sandra Milligan, Amgen Inc.

Sara Radcliffe, Biotechnology Industry Organization

The Journal Editorial Advisory Board promotes the educational, scholarly, and other purposes of the Food and Drug Law Journal. Members of the Board serve as peer reviewers for papers submitted for publication and recommend topics for “special / symposia” issues.

Jeffrey B. Chasnow, Pfizer, Inc.
Chair

Anne V. Maher, Kleinfeld, Kaplan & Becker
Vice Chair

Tracy P. Berns, Covidien

Krista Hessler Carver, Covington & Burling LLP

Kirk L. Dobbins, King & Spalding LLP

Melanie Fairchild-Dzanis,

Jeffrey K. Francer, PhRMA

Michael M. Gaba, Holland & Knight, LLP

Ralph F. Hall, University of Minnesota

Joel E. Hoffman, Sutherland Asbill & Brennan, LLP

Gregory Jaffe, J.D., Center for Science in the Public Interest

Gail H. Javitt, JD, MPH, Sidley Austin LLP

Gordon S. Jepson, Deeth Williams Wall LLP

Kyle Lathrop, W.L. Gore and Associates

Laurie Lenkel, FDA - OC

Natasha V. Leskovsek, Cooley Godward Kronish LLP

Mark C. Levy, Saul Ewing LLP

Deborah Livornese, Buc & Beardsley, LLP

Suzanne E. LoGalbo, J.D., R.Ph, Novartis Consumer Health, Inc.

Maura Martin, Sidley Austin LLP

Eric Olsen, Mars, Inc.

James T. O'Reilly, Baker & Daniels

Mark I. Schwartz, FDA - OC

Sheila R. Shulman, State University of NY at Buffalo

Bradley Merrill Thompson, Epstein Becker & Green, P.C.

David S. Weinstock, Esq., Boehringer Ingelheim Pharmaceuticals

Frances K. Wu, Personal Care Products Council

The Update Editorial Advisory Board promotes the highest levels of professional, educational, and scholarly written commentary on timely issues of interest to professionals in the areas of foods, drugs, biologics, medical devices, other healthcare technologies, and cosmetics in FDLI’s magazine The Board serves as a resource for FDLI staff to develop feature theme ideas, acquire articles of interest to readers, and advise on the magazine’s quality and success in serving the interests and needs of its readers.

Robert B. Nicholas, McDermott, Will & Emery
Chair

Barbara A. Binzak, Ph.D., J.D, Buchanan Ingersoll & Rooney PC
Vice Chair

Frederick R. Ball, Duane Morris LLP

Christopher A. Brown, Genentech, Inc.

Daniel P. Carmichael, Baker & Daniels

Megan Clark Valez, FDA - CTP

Carrie Dooher, Esq., Kleinfeld, Kaplan & Becker

Elizabeth Barr Fawell, Hogan & Hartson LLP

William A. McGrath, Wiley Rein LLP

Stephanie Philbin, Goodwin Procter LLP

Rene Y. Quashie, Drinker Biddle & Reath LLP

Larry Rosania, M.S., RAC, The Weinberg Group Inc.

Jeffrey M. Senger, FDA - OC

Sarah Zagata Vasani, King & Spalding LLP

Frederick H. Degnan, King & Spalding LLP
Chair

William B. Schultz, Zuckerman Spaeder LLP
Immediate Past Chair

Susan C. Winckler, RPh, JD, FDLI
President & CEO

Jeffrey N. Gibbs, Hyman, Phelps & McNamara, P.C.
Secretary and General Counsel

Linda A. Suydam, DPA, Consumer Healthcare Products Association
Treasurer

Minnie V. Baylor-Henry, JD, Deloitte & Touche LLP
Vice Chair

The purpose of the Finance Committee is to ensure the responsible financial operations of FDLI. The Committee provides on-going oversight of the financial operations and investment policies of FDLI to ensure sound financial management. The Committee also advises the Board on the direction and control of financial matters. The Committee also ensures that the Board is well informed about the Institute's finances.

Linda A. Suydam, DPA, Consumer Healthcare Products Association
Chair

Maxine K. Fritz, Becker & Associates Consulting, Inc.

Rady A. Johnson, Pfizer, Inc.

Brenton Saunders, Schering-Plough Corporation

The Food and Dietary Supplements Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the food and dietary supplement industries. The Committee advises staff on the appropriateness of conferences and publications relating to foods and dietary supplements by reviewing and commenting on proposals.

Steven H. Armstrong, Campbell Soup Company

Nicole Coutrelis, Coutrelis & Associes

Todd H. Halpern, Wyeth Pharmaceuticals

Regina Hildwine, Grocery Manufacturers Association

Leslie T. Krasny, Keller and Heckman LLP

Michael M. Landa, JD, FDA - OC

Rachel G. Lattimore, Arent Fox LLP

John M. Packman, The Coca-Cola Company

Edward A. Steele, EAS Consulting Group, LLC

The Medical Devices Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the Medical Devices industries. The Committee advises staff on the appropriateness of conferences and publications relating to medical devices by reviewing and commenting on proposals.

Beverly I. Chernaik, FDA - OC
Chair

Susan Alpert, PhD, MD, Medtronic, Inc.

M. Elizabeth Bierman, Morgan, Lewis & Bockius, LLP

Mark A. Heller, Goodwin Procter LLP

Sheila M. Hemeon-Heyer, JD, RAC, Boston Scientific Corporation Inc.

Charma A. Konnor, RPh, RAC, Phoenix Regulatory Associates, Ltd.

Mark B. Leahey, Medical Device Manufacturers Association

Joanne R. Less, PhD, FDA - OC

Carol A. Ley, MD, 3M Company

Steven M. Niedelman, Crowell & Moring LLP

Neil F. O'Flaherty, Olsson Frank Weeda Terman Bode Matz PC

Bradley Merrill Thompson, Epstein Becker & Green, P.C.

Casper E. Uldriks, FDA - CDRH

Committee mission statement to come.

Committee members yet to be named.